• OPEN AN ACCOUNT
Indian Indices
Sensex
78,516.08 -438.68
( -0.56%)
Global Indices
Nasdaq
53,904.84 -465.28
(-0.86%)
Dow Jones
7,729.00 -15.55
(-0.20%)
Hang Seng
65,663.80 -636.64
(-0.96%)
Nikkei 225
10,873.25 -15.05
(-0.14%)
Forex
USD-INR
95.23 -0.06
(-0.07%)
EUR-INR
109.68 -0.11
(-0.10%)
GBP-INR
127.98 -0.19
(-0.15%)
JPY-INR
0.60 0.00
(-0.60%)

EQUITY - MARKET SCREENER

Abbott India Ltd
Industry :  Pharmaceuticals - Multinational
BSE Code
ISIN Demat
Book Value()
500488
INE358A01014
2246.6776471
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ABBOTINDIA
38.31
59257.43
EPS(TTM)
Face Value()
Div & Yield %
727.9
10
2.35
 

Kopran consolidated net profit rises 94.94% in the March 2026 quarter
May 19,2026
Net profit of Kopran rose 94.94% to Rs 18.87 crore in the quarter ended March 2026 as against Rs 9.68 crore during the previous quarter ended March 2025. Sales rose 35.77% to Rs 234.02 crore in the quarter ended March 2026 as against Rs 172.36 crore during the previous quarter ended March 2025.

For the full year,net profit declined 33.26% to Rs 25.73 crore in the year ended March 2026 as against Rs 38.55 crore during the previous year ended March 2025. Sales rose 8.23% to Rs 681.42 crore in the year ended March 2026 as against Rs 629.60 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales234.02172.36 36 681.42629.60 8
OPM %14.089.92 -9.0911.58 -
PBDT29.8617.58 70 51.8367.54 -23
PBT25.3513.71 85 34.3651.95 -34
NP18.879.68 95 25.7338.55 -33